COMP <GO>
EMR vs GE // EV/EBITDA & P/E VALUATION
Emerson Electric Company (NYSE) VS. GE Aerospace (NYSE) • 15-METRIC TALLY: EMR 5
— GE 7
▲ EV/EBITDA & P/E VALUATION LEADER: GE
LAST: $164.94 (-3.40%) • MKT CAP: $95.24B
valuation
30.9x
LAST: $301.80 (-3.59%) • MKT CAP: $323.49B
valuation
28.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EMR VS. GE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EMR | GE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 52.80% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.70% | 16.80% | -7.10 | GE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 30.9x | 28.7x | +2.20 | GE | /valuation <GO> |
| Free Cash Flow Yield | 2.80% | 2.00% | +0.80 | EMR | /fcf-yield <GO> |
| Operating Margin | 15.50% | 23.20% | -7.70 | GE | /operating-margins <GO> |
| Net Profit Margin | 12.70% | 19.00% | -6.30 | GE | /net-margins <GO> |
| Revenue Growth (YoY) | 3.00% | 18.50% | -15.50 | GE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.25% | 0.00% | +1.25 | EMR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.80 | 3.32 | +1.48 | EMR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.1 | 53.6 | +10.50 | EMR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.34 | 1.24 | +0.10 | EMR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 38.6x | 31.2x | +7.40 | GE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $95.24B | $323.49B | -$228.25B | GE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EMR REV | GE REV | EMR GROSS % | GE GROSS % | EMR FCF | GE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $18.02B | $45.85B | 52.8% | — | $2.67B | $6.47B |
| FY 2024 | $17.49B | $38.70B | 50.8% | — | $2.91B | $2.97B |
| FY 2023 | $15.16B | $35.35B | — | — | -$45.4M | $3.60B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EMR // BETA 1.34
GE // BETA 1.24